Top 10 Blue Chip Stocks

The Fundamental Package includes our algorithmic forecasts for stocks screened by fundamental criteria. Our algorithms help you find best opportunities for both long and short positions for the stocks within each fundamental screen. The stocks are selected according to five basic valuation categories:

P/E (price to earnings ratio)

PEG (price/earnings to growth ratio)

price-to-book ratio

price-to-sales ratio

short ratio

Fundamental – Low price-to-book ratio stocksLong3 Months (11/10/2016 – 02/10/2017)30.17%

I Know First’s state of the art algorithm accurately forecasted 9 out of 10 trades in this Fundamental – Low price-to-book ratio stocks package given its 3 months time period. The greatest return came from ARIA at 108.66%. ARRY and CLF also performed well for this time horizon with returns of 84.18% and 55.08%, respectively. The package itself saw an overall return of 30.17%, providing investors with a 23.10% market premium above the S&P 500’s return of 7.07% for the same time period.

Ariad Pharmaceutical Inc. (ARIA) works in oncology and engages in the discovery, development, and commercialization of drugs for cancer patients in the United States and internationally. Currently treatments are chronic myeloid leukemia and Philadelphia chromosome positive acute lymphoblastic leukemia, two rare blood and bone marrow diseases.

Algorithmic traders utilize these daily forecasts by the I Know First market prediction system as a tool to enhance portfolio performance, verify their own analysis and act on market opportunities faster. This forecast was sent to current I Know First subscribers.

Please note-for trading decisions use the most recent forecast. Get today’s forecast and Top stock picks.